Relief Therapeutics Holding AG (RLFTY)

USD 3.2

(6.67%)

Revenue Summary of Relief Therapeutics Holding AG

  • Relief Therapeutics Holding AG's latest annual revenue in 2023 was 6.03 Million CHF , down -0.79% from previous year.
  • Relief Therapeutics Holding AG's latest quarterly revenue in 2024 Q2 was 2.82 Million CHF , down 0.0% from previous quarter.
  • Relief Therapeutics Holding AG reported a annual revenue of 6.08 Million CHF in annual revenue 2022, up 83.11% from previous year.
  • Relief Therapeutics Holding AG reported a annual revenue of 3.32 Million CHF in annual revenue 2021, down 0.0% from previous year.
  • Relief Therapeutics Holding AG reported a quarterly revenue of 2.82 Million CHF for 2024 Q2, down 0.0% from previous quarter.
  • Relief Therapeutics Holding AG reported a quarterly revenue of 3.01 Million CHF for 2023 Q4, up 100.0% from previous quarter.

Annual Revenue Chart of Relief Therapeutics Holding AG (2023 - 2007)

Historical Annual Revenue of Relief Therapeutics Holding AG (2023 - 2007)

Year Revenue Revenue Growth
2023 6.03 Million CHF -0.79%
2022 6.08 Million CHF 83.11%
2021 3.32 Million CHF 0.0%
2020 - CHF 0.0%
2019 - CHF -100.0%
2018 565 Thousand CHF 0.0%
2017 - CHF -100.0%
2016 15 Thousand CHF -94.14%
2015 256.11 Thousand CHF -98.69%
2014 19.49 Million CHF -5.91%
2013 20.71 Million CHF 0.0%
2012 - CHF 0.0%
2011 - CHF -100.0%
2010 386.38 Thousand CHF -97.19%
2009 13.74 Million CHF -5.53%
2008 14.54 Million CHF -1.9%
2007 14.82 Million CHF 0.0%

Peer Revenue Comparison of Relief Therapeutics Holding AG

Name Revenue Revenue Difference
Evofem Biosciences, Inc. 18.21 Million USD 66.884%
Arch Therapeutics, Inc. 75.72 Thousand USD -7867.091%
CSL Limited 14.69 Billion USD 99.959%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 95.093%
Regen BioPharma, Inc. 236.56 Thousand USD -2450.304%
BioStem Technologies, Inc. 16.68 Million USD 63.843%
Capstone Therapeutics Corp. 48.35 Million USD 87.523%
Qrons Inc. - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD -212.267%
Oncotelic Therapeutics, Inc. 70 Thousand USD -8518.571%
Skye Bioscience, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD -816.173%
Burzynski Research Institute, Inc. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.281%
Neon Bloom, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 61.751%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -34137.557%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 71.911%
Intellipharmaceutics International Inc. 65.72 Thousand USD -9078.737%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD -2.22%
Marizyme, Inc. 645.81 Thousand USD -834.176%
Genus plc 668.8 Million USD 99.098%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 97.541%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -5994.309%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -1370.871%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -7759.46%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -15166.461%
MultiCell Technologies, Inc. 49.32 USD -12232260.097%
ONE Bio Corp. 52.29 Million USD 88.464%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 87.866%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -12237.423%
Q BioMed Inc. 284.35 Thousand USD -2021.666%
Emmaus Life Sciences, Inc. 29.59 Million USD 79.616%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 95.842%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -981.745%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -603803.904%
Enzolytics Inc. 52.79 Thousand USD -11327.002%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD -891.414%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.508%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -4201.85%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -877.188%
Zenith Capital Corp. - USD -Infinity%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD -504.675%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -2450.304%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD -340.687%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -1173.51%
SYBLEU INC 11.69 Thousand USD -51481.737%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 22.545%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -46307.692%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -15160.282%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD -81.171%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 9.482%
IntelGenx Technologies Corp. 1.03 Million USD -480.654%
Gelesis Holdings, Inc. 25.76 Million USD 76.586%
CSL Limited 14.8 Billion USD 99.959%
Cellectis S.A. 755 Thousand USD -699.073%